| Autor: |
Lemieszek MK; Department of Medical Biology, Institute of Rural Health, Jaczewskiego 2, 20-090 Lublin, Poland., Chojnacki M; Department of Medical Biology, Institute of Rural Health, Jaczewskiego 2, 20-090 Lublin, Poland., Paśnik I; Department of Medical Biology, Institute of Rural Health, Jaczewskiego 2, 20-090 Lublin, Poland., Gawryś W; Department of Medical Biology, Institute of Rural Health, Jaczewskiego 2, 20-090 Lublin, Poland., Wilczyńska A; Department of Medical Biology, Institute of Rural Health, Jaczewskiego 2, 20-090 Lublin, Poland., Leśniowska I; Department of Medical Biology, Institute of Rural Health, Jaczewskiego 2, 20-090 Lublin, Poland., Anisiewicz J; Department of Medical Biology, Institute of Rural Health, Jaczewskiego 2, 20-090 Lublin, Poland. |
| Abstrakt: |
Despite numerous scientific reports on the negative impact of vitamin D3 deficiency on many respiratory diseases, little is known about the influence of this phenomenon on the development and progression of hypersensitivity pneumonitis (HP). The presented study is an attempt to shed light on this occurrence. The research was performed on mouse strain C57BL/6J exposed to the antigen of Pantoea agglomerans (etiological factor of HP). To induce vitamin D3 deficiency, mice received a diet with a 10 times lower amount of cholecalciferol than the main control group. VD3-deficient mice inhaled 25(OH)-VD3 or 1,25(OH)2-VD3 used separately or with SE-PA. At the beginning of the experiment and after 14 and 28 days of inhalation, respiratory function was examined using whole-body plethysmography. Moreover, at indicated time points, mice were sacrificed and samples collected for histological examination, flow cytometry, and ELISA. The performed study revealed that inhalations with 25(OH)-VD3 and 1,25(OH)2-VD3 effectively eliminated most of the negative changes in the respiratory system caused by vitamin D3 deficiency by restoring the physiological concentration of 1,25(OH) 2 -VD3 in the body. VD3-deficient mice which inhaled P. agglomerans antigen and vitamin D3 metabolites also demonstrated the ability of the tested compounds to eliminate, or at least weaken, the negative effects of the HP causative factor and desired effect, including improvement of respiratory functions and attenuation of inflammation and signs of fibrosis. The obtained results suggested that the beneficial influence of inhaled vitamin D3 metabolites on HP development was associated with the restoration of the physiological concentration of 1,25(OH)2-VD3 in the pulmonary compartments in VD3-deficient mice. |
